Editors:
Will provide an update of the latest treatments for AIDS defining cancers, a scientific rationale for established treatments and a review of novel molecularly-targeted treatment options, which have passed pre-clinical testing
Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (14 chapters)
-
Front Matter
-
Back Matter
About this book
Cancer incidences increase in people living with HIV/AIDS. Over 2 million people currently live with HIV/AIDS in the US. This number will increase as HAART prolongs the average lifespan and as (at least in some states) the number of new HIV infections increase again. As this population ages their incidence rates for cancer will increase, as well.
Recently, new rational targets for cancer therapy have emerged. But their application to the care of HIV+ patients is slow, because of concerns about the weakened immune status of the patients, because of possible drug interactions with HAART and because some of the AIDS defining cancer are rare.
Editors and Affiliations
-
Lineberger Comprehensive, Cancer Center, University of North Carolina, Chapel Hill, USA
Dirk P. Dittmer
-
Cancer Center, Memorial Sloan-Kettering, New York, USA
Susan E. Krown
Bibliographic Information
Book Title: Molecular Basis for Therapy of AIDS-Defining Cancers
Editors: Dirk P. Dittmer, Susan E. Krown
DOI: https://doi.org/10.1007/978-1-4419-1513-9
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media, LLC 2010
Hardcover ISBN: 978-1-4419-1512-2Published: 08 June 2010
Softcover ISBN: 978-1-4899-8200-1Published: 06 September 2014
eBook ISBN: 978-1-4419-1513-9Published: 14 June 2010
Edition Number: 1
Number of Pages: XIII, 256
Topics: Cancer Research, Pharmacology/Toxicology, Infectious Diseases